1. Home
  2. EOLS vs INN Comparison

EOLS vs INN Comparison

Compare EOLS & INN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • INN
  • Stock Information
  • Founded
  • EOLS 2012
  • INN 2010
  • Country
  • EOLS United States
  • INN United States
  • Employees
  • EOLS N/A
  • INN N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • INN Real Estate Investment Trusts
  • Sector
  • EOLS Health Care
  • INN Real Estate
  • Exchange
  • EOLS Nasdaq
  • INN Nasdaq
  • Market Cap
  • EOLS 787.7M
  • INN 692.3M
  • IPO Year
  • EOLS 2018
  • INN 2011
  • Fundamental
  • Price
  • EOLS $12.11
  • INN $6.19
  • Analyst Decision
  • EOLS Strong Buy
  • INN Hold
  • Analyst Count
  • EOLS 6
  • INN 1
  • Target Price
  • EOLS $22.60
  • INN N/A
  • AVG Volume (30 Days)
  • EOLS 672.0K
  • INN 654.7K
  • Earning Date
  • EOLS 11-06-2024
  • INN 11-04-2024
  • Dividend Yield
  • EOLS N/A
  • INN 5.17%
  • EPS Growth
  • EOLS N/A
  • INN N/A
  • EPS
  • EOLS N/A
  • INN 0.07
  • Revenue
  • EOLS $248,326,000.00
  • INN $736,287,000.00
  • Revenue This Year
  • EOLS $33.57
  • INN $0.45
  • Revenue Next Year
  • EOLS $32.91
  • INN $1.46
  • P/E Ratio
  • EOLS N/A
  • INN $85.54
  • Revenue Growth
  • EOLS 34.42
  • INN 0.72
  • 52 Week Low
  • EOLS $9.00
  • INN $5.66
  • 52 Week High
  • EOLS $17.82
  • INN $7.22
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 26.80
  • INN 41.45
  • Support Level
  • EOLS $16.12
  • INN $6.43
  • Resistance Level
  • EOLS $17.44
  • INN $6.60
  • Average True Range (ATR)
  • EOLS 0.75
  • INN 0.19
  • MACD
  • EOLS -0.48
  • INN 0.01
  • Stochastic Oscillator
  • EOLS 12.19
  • INN 34.51

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About INN Summit Hotel Properties Inc.

Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The firm's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.

Share on Social Networks: